MODIFICATION TO ALCYON DIRECT BILIRUBIN— 510(k) K991175
Substantially EquivalentAbbott Laboratories
FDA 510(k) clearance K991175 for MODIFICATION TO ALCYON DIRECT BILIRUBIN, Substantially Equivalent on 1999-05-28. Applicant: Abbott Laboratories.
Clearance details
- Applicant
- Abbott Laboratories
- Product code
- Code CIG
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Irving, TX, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.